Lukoon

Italy Single Photon Emission Computed Tomography Market Size, Share, and Future Opportunities by 2035

2 min read
0
Comments
34
Views

Single Photon Emission Computed Tomography (SPECT) continues to serve as a cornerstone of nuclear medicine across medical centers in Italy. As outlined in industry analyses of the Italy Single Photon Emission Computed Tomography Market, technological innovations in gamma camera design and radiopharmaceutical development are continuously broadening the clinical utility of SPECT scans from cardiology to oncology, neurology, and orthopedics.

Cardiology: Myocardial Perfusion Imaging (MPI)

Cardiology accounts for the largest share of SPECT procedures performed in Italy. Myocardial Perfusion Imaging remains the gold standard for evaluating coronary artery disease (CAD), assessing myocardial viability, and evaluating left ventricular function. The integration of solid-state Cadmium Zinc Telluride (CZT) detectors into dedicated cardiac SPECT systems has revolutionized cardiac imaging in Italian facilities. CZT-based detectors offer superior energy resolution and higher sensitivity, enabling shorter acquisition times and reduced radiotracer dosages for patients.

Neurology and Movement Disorders

SPECT plays a pivotal diagnostic role in Italian neurology departments, particularly for differentiating neurodegenerative movement disorders.

  • Parkinson’s Disease: Dopamine transporter (DaT) imaging using SPECT helps clinicians differentiate essential tremor from presynaptic parkinsonian syndromes.

  • Dementia: Brain perfusion SPECT assists in evaluating regional cerebral blood flow patterns to aid in the early differential diagnosis of Alzheimer’s disease and frontotemporal dementia.

Oncology and Bone Scintigraphy

In oncology, SPECT remains a frontline tool for detecting bone metastases originating from prostate, breast, and lung cancers. Whole-body bone scintigraphy paired with hybrid SPECT/CT allows Italian radiologists to accurately localize equivocal bone lesions, reducing the need for additional follow-up procedures.

Radiopharmaceutical Innovations

The growth of SPECT imaging in Italy is closely tied to the steady availability of key radioisotopes, most notably Technetium-99m (Tc-99m). Italian nuclear medicine centers are adopting novel Tc-99m labeled kits and targeted radiopharmaceuticals that offer higher specificity and reduced preparation times, improving overall clinical workflow and patient care quality across regional hospital networks.